Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bicycle Therapeutics Plc ADR shares valued at $75,192 were sold by Lee Kevin on Apr 03 ’24. At $23.81 per share, Lee Kevin sold 3,158 shares. The insider’s holdings dropped to 387,270 shares worth approximately $8.9 million following the completion of this transaction.
Also, Crockett Nigel sold 955 shares, netting a total of over 22,739 in proceeds. Following the sale of shares at $23.81 each, the insider now holds 47,761 shares.
Before that, Milnes Alistair had sold 955 shares from its account. In a trade valued at $22,739, the CHIEF OPERATING OFFICER traded Bicycle Therapeutics Plc ADR shares for $23.81 each. Upon closing the transaction, the insider’s holdings decreased to 955 shares, worth approximately $1.66 million.
As published in a research note from B. Riley Securities on September 11, 2023, Bicycle Therapeutics Plc ADR [BCYC] has been rated up from a Neutral to a Buy. Analysts at Cowen started covering the stock with ‘”an Outperform”‘ outlook in a report released in late August. As of July 28, 2022, Barclays has initiated its “an Overweight” rating for BCYC.
Analyzing BCYC Stock Performance
During the last five days, there has been a drop of approximately -1.42%. Over the course of the year, Bicycle Therapeutics Plc ADR shares have jumped approximately 27.16%. Shares of the company reached a 52-week high of $27.24 on 02/28/24 and a 52-week low of $16.13 on 01/05/24. A 50-day SMA is recorded $22.77, while a 200-day SMA reached $20.44. Nevertheless, trading volume fell to 0.61 million shares from 0.36 million shares the previous day.
Support And Resistance Levels for Bicycle Therapeutics Plc ADR (BCYC)
According to the 24-hour chart, there is a support level at 22.46, which, if violated, would cause prices to drop to 21.94. In the upper region, resistance lies at 23.39. The next price resistance is at 23.80. RSI (Relative Strength Index) is 44.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.02, which suggests the price will decrease in the coming days. Percent R is at 80.05%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Bicycle Therapeutics Plc ADR subject to short interest?
Stocks of Bicycle Therapeutics Plc ADR saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.83 million shares to 2.56 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 3.39 million shares. A decline of -32.42% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.4 of the overall float, the days-to-cover ratio (short ratio) decline to 6.4.
